Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting

摘要

New targeted and immunotherapies expand the treatment options for metastatic nonesmall-cell lung cancer. In this study we assessed contemporary treatment patterns and outcomes using a large electronic health record database of 10,000 patients. Most targeted and immunotherapy use was in the second-and third-line treatment setting. Survival differences observed according to treatment type suggest that patients with actionable mutations have a survival advantage.